We are live on ! Find out more
ARAV

Aravive, Inc. Common Stock

Delisted

ARAV was delisted on the 26th of January, 2024.

35 hedge funds and large institutions have $38.3M invested in Aravive, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 9

13% less funds holding

Funds holding: 4035 (-5)

36% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 14

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

56% less capital invested

Capital invested by funds: $86.2M → $38.3M (-$47.9M)

Holders
35
Holders Change
-5
Holders Change %
-12.5%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
9
Increased
12
Reduced
9
Closed
14
Calls
$8K
Puts
Net Calls
+$8K
Net Calls Change
-$562K
Name Holding Trade Value Shares
Change
Change in
Stake
AG
1
Artal Group
Luxembourg
$8.35M +$896K +100,000 +7%
NLVP
2
New Leaf Venture Partners
New York
$5.45M
Fidelity Investments
3
Fidelity Investments
Massachusetts
$4.03M
SB
4
Samsara BioCapital
California
$3.32M
Renaissance Technologies
5
Renaissance Technologies
New York
$3.12M +$1.97M +219,977 +68%
BBA
6
Baker Bros. Advisors
New York
$2.8M +$475K +53,000 +12%
Vanguard Group
7
Vanguard Group
Pennsylvania
$2.77M +$692K +77,323 +19%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$1.23M +$232K +25,872 +14%
BlackRock
9
BlackRock
New York
$1.16M -$119K -13,330 -6%
Two Sigma Advisers
10
Two Sigma Advisers
New York
$923K +$738K +82,462 +106%
AGM
11
Alpine Global Management
New York
$894K +$479K +53,433 +53%
Two Sigma Investments
12
Two Sigma Investments
New York
$739K -$210K -23,433 -15%
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$526K +$449K +50,165 +122%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$502K +$176K +19,653 +29%
UBS Group
15
UBS Group
Switzerland
$460K -$18.9K -2,112 -3%
SCM
16
Sio Capital Management
New York
$441K -$194K -21,687 -22%
Millennium Management
17
Millennium Management
New York
$325K +$506K +56,470 New
Connor, Clark & Lunn Investment Management (CC&L)
18
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$227K +$353K +39,450 New
Bank of Montreal
19
Bank of Montreal
Ontario, Canada
$155K -$395K -44,154 -60%
BCM
20
Bridgeway Capital Management
Texas
$149K +$71K +7,926 +44%
Northern Trust
21
Northern Trust
Illinois
$128K +$896 +100 +0.5%
Wells Fargo
22
Wells Fargo
California
$114K +$32.4K +3,616 +22%
Invesco
23
Invesco
Georgia
$96K +$150K +16,700 New
WS
24
Wedbush Securities
California
$92K +$142K +15,900 New
Morgan Stanley
25
Morgan Stanley
New York
$89K -$42.6K -4,754 -23%

ARAV Hedge Fund Activity: Q1 2020 in Review

35 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q1 2020, worth a combined $38.3M — down 56% from $86.2M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of ARAV and 9 opened new positions — a net loss of 5 holders — while 9 trimmed existing stakes and 12 added.

The largest buyer was Renaissance Technologies, adding an estimated $1.97M. The largest seller was Maven Securities, exiting entirely with an estimated $2.04M sold.

  • 35 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q1 2020, down from 40 in Q4 2019.
  • Funds reported $38.3M of Aravive, Inc. Common Stock stock for Q1 2020, down 56% quarter-over-quarter.
  • 9 funds opened new Aravive, Inc. Common Stock positions in Q1 2020 and 14 closed out, a net change of -5 holders.
  • The largest Aravive, Inc. Common Stock buyer in Q1 2020 was Renaissance Technologies, an estimated $1.97M added.
  • The largest Aravive, Inc. Common Stock seller in Q1 2020 was Maven Securities, an estimated $2.04M sold.

Based on aggregated 13F filings for Q1 2020.